Physician

Alexander C Whitley, MD PHD

According to 2025 Medicare claims, Alexander Whitley, MD PHD (NPI: 1063648509) practices radiation oncology in the Montgomery, AL market, with the plurality of this provider's patient population coming from Montgomery, AL. This provider's primary affiliated billing organization is CENTRAL ALABAMA RADIATION ONCOLOGY (NPI: 1659644706; TIN: 454048337) and primary practice location at 36106-2801.

Whitley's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 335 traditional Medicare patients, billed 4,676 HCPCS/CPT codes, and received $752,866 in Medicare payments. The top billing code was G6015 (Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session). Part D data shows 350 prescription claims across 173 beneficiaries totaling $55,201 in drug costs, led by Mometasone Furoate (Mometasone Furoate). DME data shows 12 claims. Open Payments data shows 52 records totaling $64,015. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $4,390 to $55,201. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	333	5,475	$822,314
2016	388	4,852	$738,928
2017	335	5,628	$930,556
2018	395	5,911	$969,497
2019	444	6,521	$1,078,229
2020	405	5,940	$1,011,378
2021	343	4,258	$735,944
2022	404	5,010	$880,834
2023	375	3,877	$647,855
2024	335	4,676	$752,866

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	56	133	$4,390
2016	66	157	$8,096
2017	84	191	$4,658
2018	118	273	$9,272
2019	141	294	$12,996
2020	123	265	$11,295
2021	89	228	$7,970
2022	136	274	$11,722
2023	150	328	$12,969
2024	173	350	$55,201

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	24	$144,211
2024	N/R	12	$147,395

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G6015	Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session	118	900	$261
77427	Radiation treatment management, 5 treatment sessions	97	319	$149
77014	Ct guidance for insertion of radiation therapy fields	108	751	$90
77336	Continuing radiation therapy consultation per week	111	337	$64
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	107	152	$61

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Mometasone Furoate	Mometasone Furoate	76	2,802	$2,356
Ssd	Silver Sulfadiazine	27	912	$1,098
Tamsulosin Hcl	Tamsulosin Hcl	61	4,533	$1,096
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	32	364	$775
Dexamethasone	Dexamethasone	17	554	$612

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0766	Electrical stimulation device used for cancer treatment, includes all accessories, any type	Y	N/R	12	$147,395

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	52	$64,015	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Alexander C. Whitley, MD PHD?

Tedicare shows public-source Medicare data for Alexander C. Whitley, MD PHD (NPI 1063648509), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alexander C. Whitley, MD PHD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Alexander C. Whitley, MD PHD?

Alexander C. Whitley, MD PHD is linked to CENTRAL ALABAMA RADIATION ONCOLOGY (billing NPI 1659644706) in the available physician profile data.

Does Alexander C. Whitley, MD PHD have Open Payments data?

Alexander C. Whitley, MD PHD has 52 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.